Using the NLRP3-S194A knock-in mice, we demonstrated that NLRP3 S194A mutation significantly protects mice from LPS-induced endotoxemia and monosodium urate (MSU)-induced peritoneal inflammation. Here, NLRP3 is linked to serum lipopolysaccharide activity.